Endo International PLC ENDP shares are trading lower by 35% at $2.31 following a Wall Street Journal report indicating the company has engaged a restructuring adviser to explore options amid opioid-related lawsuits.
Endo International shares were trading higher during the July 22nd session after the company announced it reached an agreement in principle to pay $35 million to settle an ongoing Opioid case in Tennessee. Since July 22nd, shares are trading lower by around 53%.
Endo International is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology and bariatrics.
Endo International has a 52-week $10.89 and a 52-week low of $2.23.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
